The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Assembly of microtubule-associated protein tau into Alzheimer-like filaments induced by sulphated glycosaminoglycans
Abstract
The paired helical filament (PHF) is the major component of the neurofibrillary deposits that form a defining neuropathological characteristic of Alzheimer's disease. PHFs are composed of microtubule-associated protein tau, in a hyperphosphorylated state. Hyperphosphorylation of tau results in its inability to bind to microtubules and is believed to precede PHF assembly. However, it is unclear whether hyperphosphorylation of tau is either necessary or sufficient for PHF formation. Here we show that non-phosphorylated recombinant tau isoforms with three microtubule-binding repeats form paired helical-like filaments under physiological conditions in vitro, when incubated with sulphated glycosaminoglycans such as heparin or heparan sulphate. Furthermore, heparin prevents tau from binding to microtubules and promotes microtubule disassembly. Finally, we show that heparan sulphate and hyperphosphorylated tau coexist in nerve cells of the Alzheimer's disease brain at the earliest known stages of neurofibrillary pathology. These findings, with previous studies which show that heparin stimulates tau phosphorylation by a number of protein kinases, indicate that sulphated glycosaminoglycans may be a key factor in the formation of the neurofibrillary lesions of Alzheimer's disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Tau aggregation is promoted by proteoglycans [186], which are present in tangles, and are involved in the prion-like spread of tau pathology [187].”
From The extracellular matrix and perineuronal nets in memory (2022) · cites this paper as [186]
In the citing paper
“that this molecule can be used as an in vitro inducer of aggregation38”
From Tau Internalization is Regulated by 6-O Sulfation on Heparan Sulfate Proteoglycans (HSPGs) (2018) · cites this paper as [38]
In the citing paper
“it has been known for years that tau can bind heparin”
From Tau Internalization is Regulated by 6-O Sulfation on Heparan Sulfate Proteoglycans (HSPGs) (2018) · cites this paper as [38]
In the citing paper
“anionic experimental cofactor models have been described to promote aggregation: heparin (Goedert et al., 1996; Fichou et al., 2018) and RNA or its associated granules (Kampers et al., 1996; Zhang et al., 2017; Dinkel et al., 2015).”
From Tau PTM Profiles Identify Patient Heterogeneity and Stages of Alzheimer’s Disease (2020) · cites this paper as Goedert et al., 1996
Citations
Cites
Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80190-4 · Cited by 5,404
Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease
Sherrington, R., Rogaev, E. I., Liang, Y., Rogaeva, E. A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li, G., Holman, K., et al. (1995) · Nature · doi:10.1038/375754a0 · Cited by 4,051
A68: a Major Subunit of Paired Helical Filaments and Derivatized Forms of Normal Tau
Lee, V. M.-Y., Balin, B. J., Otvos, L., & Trojanowski, J. Q. (1991) · Science · doi:10.1126/science.1899488 · Cited by 1,418
Goedert, M., Wischik, C. M., Crowther, R. A., Walker, J. E., & Klug, A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.11.4051 · Cited by 1,134
Self-citationGoedert, M., Spillantini, M. G., Cairns, N. J., & Crowther, R. A. (1992) · Neuron · doi:10.1016/0896-6273(92)90117-v · Cited by 1,122
Self-citationWischik, C. M., Novak, M., Thøgersen, H. C., Edwards, P. C., Runswick, M. J., Jakes, R., Walker, J. E., Milstein, C., Roth, M., & Klug, A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.12.4506 · Cited by 939
Self-citationGoedert, M., & Jakes, R. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb07870.x · Cited by 929
Self-citationBramblett, G. T., Goedert, M., Jakes, R., Merrick, S. E., Trojanowski, J. Q., & Lee, V. M. Y. (1993) · Neuron · doi:10.1016/0896-6273(93)90057-x · Cited by 903
Self-citationBraak, F., Braak, H., & Mandelkow, E. (1994) · Acta Neuropathologica · doi:10.1007/bf00293315 · Cited by 769
Tau protein and the neurofibrillary pathology of Alzheimer's disease
Goedert, M. (1993) · Trends in Neurosciences · doi:10.1016/0166-2236(93)90078-z · Cited by 721
Self-citation
Research works printed but not linked: 2
- Brandt, R., Lee, G., Teplow, D. B., Shalloway, D. & Abdel-Ghany, M. J. Biol. Chem. 269, 11176–11782 (1994).
- Snow, A. D. et al. Am. J. Pathol. 137, 1253–1270 (1990).
Cited by
Sorted by citations
Items 801–900 of 1,000
Molekulare Medizin der Alzheimer-Krankheit
Hoyer, S., Frölich, L., & Sandbrink, R. (1999) · Springer eBooks · doi:10.1007/978-3-662-07096-3_7 · Cited by 6
Moreno‐Herrero, F., Colchero, J., Gómez‐Herrero, J., Baró, A. M., & Ávila, J. (2004) · European Polymer Journal · doi:10.1016/j.eurpolymj.2004.01.018 · Cited by 6
Preservation of hippocampal pyramidal cells in paraphrenia
Casanova, M. F. (2003) · Schizophrenia Research · doi:10.1016/s0920-9964(02)00409-7 · Cited by 6
Introduction to the Tauopathies
Goedert, M. (2011) · Wiley eBooks · doi:10.1002/9781444341256.ch13 · Cited by 6
Self-citationPotential therapeutic targets for Alzheimer’s disease
McKeon‐O'Malley, C., Saunders, A. J., Bush, A. I., & Tanzi, R. E. (1998) · Emerging Therapeutic Targets · doi:10.1517/14728222.2.2.157 · Cited by 6
Inert and seed-competent tau monomers suggest structural origins of aggregationPreprint
Mirbaha, H., Chen, D., Morozova, O. A., Ruff, K. M., Sharma, A., Liu, X., Pappu, R. V., Colby, D. W., Mirzaei, H., Joachimiak, Ł. A., et al. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/163394 · Cited by 10
[11C]MODAG 005 – a novel PET tracer targeting alpha-synuclein aggregates in the brainPreprint
Saw, R. S., Buss, S., Schmidt, F., Ryazanov, S., Leonov, A., Kuebler, L., Bleher, D., Papadopoulos, I., Röeben, B., Schmidt, F. P., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-2189800/v1 · Cited by 6
Lövestam, S., Wagstaff, J. L., Katsinelos, T., Shi, J., Freund, S. M. V., Goedert, M., & Scheres, S. H. W. (2025) · eLife · doi:10.7554/elife.104778.2 · Cited by 6
Self-citationProtein Phosphatase 5-Recruiting Chimeras for Accelerating Tau Dephosphorylation
Gu, J., He, C., Han, Z., Huang, Q., He, Y., Lu, Y., You, Q., Zhang, Q., & Wang, L. (2025) · ACS Chemical Biology · doi:10.1021/acschembio.5c00165 · Cited by 5
de Mattos, B. A., Tomas‐Grau, R. H., Fernandes, T. A. A., González‐Lizárraga, F., Tourville, A., Ciss, I., Brunel, J. M., Chehín, R. N., Lannuzel, A., Ferrié, L., et al. (2025) · Biomolecules · doi:10.3390/biom15070941 · Cited by 6
Protein Coaggregation in Caribbean Atypical Parkinsonism: The Contribution of Annonacin
González‐Lizárraga, F., Boluda, S., Hidalgo, J. R., Ávila, C. L., Santos, C. D., Socias, B., Medina, L., Chaumont, H., Akbar, D., Roze, E. F., et al. (2025) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.70026 · Cited by 5
Making tau amyloid models in vitro: a crucial and underestimated challenge
Broc, J., Piersson, C., & Fichou, Y. (2025) · FEBS Letters · doi:10.1002/1873-3468.70022 · Cited by 5
Wickramasinghe, S. P., & Rhoades, E. R. (2020) · Methods in molecular biology · doi:10.1007/978-1-0716-0524-0_39 · Cited by 5
Molecular Mechanism of Tau Misfolding and Aggregation: Insights from Molecular Dynamics Simulation
Zhong, H., Liu, H., & Liu, H. (2023) · Current Medicinal Chemistry · doi:10.2174/0929867330666230409145247 · Cited by 5
Hassan, M. S. O., Vahid, A. A., Sahayaraj, A. E., Viswanathan, R., & Vijayan, V. (2023) · The Journal of Physical Chemistry Letters · doi:10.1021/acs.jpclett.3c00912 · Cited by 5
Protein Degradation in Alzheimer’s Disease and Aging of the Brain
Tsuji, T., & Shimohama, S. (2002) · Progress in molecular and subcellular biology · doi:10.1007/978-3-642-56373-7_4 · Cited by 5
Do aluminium and/or glutamate induce Alzheimer PHF-like formation? An electron microscopic study
Jones, K. R., Black, M. J., & Oorschot, D. E. (1998) · Journal of Neurocytology · doi:10.1023/a:1006939020525 · Cited by 5
Pathobiological features in neurodegenerative diseases: an overview
Higuchi, M., Trojanowski, J. Q., & Lee, V. M. ‐. (2003) · International Congress Series · doi:10.1016/s0531-5131(03)01567-x · Cited by 5
Development of a Fluorescent High Throughput Assay for Tau Aggregation
Liu, M., Ni, J., Kosik, K. S., & Yeh, L.-A. (2004) · Assay and Drug Development Technologies · doi:10.1089/adt.2004.2.609 · Cited by 5
HSPG2 Gene C/A Polymorphism Does Not Confer Susceptibility to Alzheimer’s Disease in Chinese
Wang, B., Jin, F., Yang, Z., Lu, Z., Zheng, C., & Wang, L. (2007) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000100902 · Cited by 5
Chaperone-Like Manner of Human Neuronal Tau Towards Lactate Dehydrogenase
Tian, R., Nie, C., & He, R. (2004) · Neurochemical Research · doi:10.1023/b:nere.0000042213.68600.65 · Cited by 5
Islam, M., Karim, M. R. U., Argueta, E., Selim, M. N., Wojcikiewicz, E. P., & Du, D. (2025) · Membranes · doi:10.3390/membranes15070208 · Cited by 4
Reversibility and β-sheet formation are decoupled in tau condensate aging
Fischer, C. M., Edu, I. A., Šneideris, T., Baronaitė, I., Toprakcioglu, Z., Deck, L.-T., Qian, D., Scrutton, R. M., Dreyer, L. S., Wen, J., et al. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2522993123 · Cited by 5
Amyloid Hypothesis and Alzheimer's Disease
Sun, X., & Zhang, Y. (2011) · InTech eBooks · doi:10.5772/28947 · Cited by 4
Cryo-EM structural analyses reveal diverse porous structures in brain-derived tau oligomers
Dasari, A. K. R., Bhatt, N. N., Haque, M. A., Irving, R., Kayed, R., & Lim, K. H. (2025) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2025.152189 · Cited by 4
Insights into neurodegeneration from electron microscopy studies
Crowther, R. A. (2021) · Biochemical Society Transactions · doi:10.1042/bst20210719 · Cited by 5
Self-citationMolecular polymorphism of tau aggregates in Pick's disease
Liu, J., Connors, T. R., Oakley, D. H., Hyman, B. T., Burghammer, M. C., Cotte, M., & Makowski, L. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.107104 · Cited by 4
Chaudhary, N., & Nagaraj, R. (2012) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-94-007-5416-4_4 · Cited by 4
Lim, M. J., Boschen, S. L., Kurti, A., Casey, M. C., Phillips, V. R., Fryer, J. D., Dickson, D. W., Jansen‐West, K. R., Petrucelli, L., Delenclos, M., et al. (2023) · Biomedicines · doi:10.3390/biomedicines11102863 · Cited by 4
Kaur, J., Giri, A., & Bhattacharya, M. (2020) · European Biophysics Journal · doi:10.1007/s00249-020-01447-8 · Cited by 4
Giannakopoulos, P., Kövari, E., Gold, G., Hof, P. R., & Bouras, C. (2001) · Elsevier eBooks · doi:10.1016/b978-012351830-9/50008-1 · Cited by 4
Minimalistic in vitro systems for investigating tau pathology
Hallinan, G. I., Pitera, A. P., Patel, P., West, J. J., & Deinhardt, K. (2018) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2018.09.032 · Cited by 4
Polyserine peptides are toxic and exacerbate tau pathology in micePreprint
Alstyne, M. V., Nguyen, V. L., Hoeffer, C. A., & Parker, R. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.10.10.616100 · Cited by 4
Structures of ΔD421 Truncated Tau Fibrils
Mammeri, N. E., Duan, P., & Hong, M. (2025) · Journal of Molecular Biology · doi:10.1016/j.jmb.2025.169051 · Cited by 3
Wu, J., Titterton, K., Sebastian, R. M., Romanul, N., Yanamandra, K., Mastis, B., Chang, R., Khasnavis, S., Kwon, T., Chai, Y., et al. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.110853 · Cited by 3
Solubility and Metastability of the Amyloidogenic Core of Tau
Axell, E., Carlsson, A., Lindberg, M., Bernfur, K., Sparr, E., & Linse, S. S. (2026) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5c00784 · Cited by 3
Lövestam, S., Wagstaff, J. L., Katsinelos, T., Shi, J., Freund, S. M. V., Goedert, M., & Scheres, S. H. W. (2026) · eLife · doi:10.7554/elife.104778.4 · Cited by 3
Self-citationMontgomery, K. M., Samelson, A. J., & Gestwicki, J. E. (2023) · Israel Journal of Chemistry · doi:10.1002/ijch.202300104 · Cited by 4
Polymerization of recombinant tau core fragments in vitro and seeding studies in cultured cells
Paterno, G., Bell, B. M., Riley-DiPaolo, A., LaVoie, M. J., & Giasson, B. I. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1268360 · Cited by 3
Liao, H., Jiang, L., & Yao, T. (2013) · The Scientific World JOURNAL · doi:10.1155/2013/354730 · Cited by 3
Ishida, T. (2009) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.57.1309 · Cited by 3
Small-molecule compound from AlphaScreen disrupts tau-glycan interface
Faris, S., Jin, W., Gibson, J. M., Murray, A., Smith, N. S., He, P., Zhang, F., Linhardt, R. J., & Wang, C. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.1083225 · Cited by 3
Neander, L., Hannemann, C., Netz, R. R., & Sahoo, A. K. (2025) · JACS Au · doi:10.1021/jacsau.4c00886 · Cited by 5
Yeast surface display of full‐length human microtubule‐associated protein tau
Wang, S., & Cho, Y. K. (2019) · Biotechnology Progress · doi:10.1002/btpr.2920 · Cited by 3
Commercial and Instant Coffees Effectively Lower Aβ1-40 and Aβ1-42 in N2a/APPswe Cells
Zhang, L., Cao, J. A., Yang, H., Pham, P., Khan, U., Brown, B., Wang, Y., Zieneldien, T., & Cao, C. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.850523 · Cited by 3
Tau Protein Expression in Adult Bovine Oligodendrocytes: Functional and Pathological Significance
Ksiȩżak-Reding, H., Farooq, M., Yang, L., Dickson, D. W., & LoPresti, P. (2003) · Neurochemical Research · doi:10.1023/a:1024952600774 · Cited by 4
Garth, F. (2011) · InTech eBooks · doi:10.5772/27973 · Cited by 3
Inhibition of Tau Aggregation as a Basis for Treatment and Prevention of Alzheimer’s Disease
Wischik, C. M., Storey, J. M. D., Wischik, D., & Harrington, C. R. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802173-6.00015-0 · Cited by 3
Parkinsonism-Plus Syndromes and Secondary Parkinsonian Disorders
Fahn, S., Jankovic, J. J., Hallett, M., & Jenner, P. G. (2007) · Elsevier eBooks · doi:10.1016/b978-0-443-07941-2.50013-9 · Cited by 3
Zhang, M., Cheng Ann, C. H. E. N., Peng, Q., Wu, X., Zhou, R., Ma, Y., & Zou, Z. (2023) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2023.02.017 · Cited by 4
Mandelkow, E., Thies, E., & MANDELKOW, E. (2007) · Springer eBooks · doi:10.1007/978-0-387-35135-3_14 · Cited by 4
Mudher, A. K., Mellanby, J. H., McMath, H., Perry, V. H., & Greene, J. R. T. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00533-8 · Cited by 3
NMR metabolomics techniques and mathematical tools as an aid in neurological diagnosis
Jukarainen, N. (2009) · UEF eRepo (University of Eastern Finland) · Cited by 3
Progressive Supranuclear Palsy and Corticobasal Degeneration
Geser, F., Scholz, S. W., & Wenning, G. K. (2007) · Springer eBooks · doi:10.1007/978-0-387-30377-2_8 · Cited by 3
Aluminum, Tau and Neurofibrillary Degeneration
Shin, R. (2001) · Elsevier eBooks · doi:10.1016/b978-044450811-9/50046-x · Cited by 3
Fibril formation rewires interactome of the Alzheimer protein Tau by π-stackingPreprint
Ferrari, L., Stucchi, R., Konstantoulea, A., van de Kamp, G., Kos, R., Geerts, W. J. C., Förster, F. G., Altelaar, M. A. F., Hoogenraad, C. C., & Rüdiger, S. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/522284 · Cited by 3
The extracellular chaperone Clusterin enhances Tau aggregate seeding in a cellular modelPreprint
Yuste‐Checa, P., Trinkaus, V. A., Riera-Tur, I., Imamoglu, R., Schaller, T., Wang, H., Dudanova, I., Hipp, M. S., Bracher, A., & Hartl, F. U. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.07.16.452659 · Cited by 4
Biomolecular Tau condensation is linked to Tau accumulation at the nuclear envelopePreprint
Hochmair, J., Exner, C., Franck, M., Dominguez‐Baquero, A., Diez, L., Brognaro, H., Kraushar, M. L., Mielke, T., Radbruch, H., Kaniyappan, S., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.01.24.477544 · Cited by 3
Central and peripheral tau retention modulated by an anti-tau antibodyPreprint
Solorzano, A. G., Brady, M., Bhatt, N. N., Johnson, A., Burgess, B., Leyva, H., Puangmalai, N., Jerez, C., Wood, R. W., Kayed, R., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.08.17.553682 · Cited by 4
A high-throughput drug screening assay for anti-tau aggregation using split GFP and flow cytometry
Ibrahium, O. M. H., Ademoye, T. A., Fortin, J. S., & Ostafe, R. (2025) · Scientific Reports · doi:10.1038/s41598-025-21680-5 · Cited by 2
Structural and mechanistic characterization of heparin interactions with tau fibrils
Mon, F., & Straub, J. E. (2026) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2026.111153 · Cited by 2
Electric Double Layer Phenomena Near Surfaces Irreversibly Trigger Assembly of Tau Protein
Masquelier, E., Hicks, M. H., Watkins, N. B., Lim, N., Yi, J., Morse, D. E., Sepunaru, L., & Gordon, M. J. (2026) · Journal of the American Chemical Society · doi:10.1021/jacs.5c23171 · Cited by 2
Viola, G., Sperotto, A., Palmioli, A., Tira, R., Munari, F., Assfalg, M., Airoldi, C., & D’Onofrio, M. (2026) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.5c17659 · Cited by 2
Martinez‐Finley, E. J., Chakraborty, S., Caito, S., Fretham, S. J. B., & Aschner, M. (2012) · PubMed · Cited by 3
Bloom, G. S., & Baas, P. W. (2023) · Cytoskeleton · doi:10.1002/cm.21783 · Cited by 2
EFhd2 co-aggregates with monomeric and filamentous tau in vitro
Soliman, A. S., Umstead, A., Lamp, J. A., & Vega, I. E. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1373410 · Cited by 2
Structure and function of Full-length Tau
Vallés‐Saiz, L., Domene-Serrano, I., Picher, Á. J., Pérez, M., García‐Escudero, V., Hernández, F., & Ávila, J. (2025) · PLoS ONE · doi:10.1371/journal.pone.0335251 · Cited by 2
Glycosaminoglycans, Proteoglycans, and Conformational Disorders
Cole, G. J., & Liu, I.-H. (2007) · Springer eBooks · doi:10.1007/0-387-25919-8_5 · Cited by 2
Progress in Familial Parkinson's Disease.
Mizuno, Y., Hattori, N., Asakawa, S., Shimura, H., Mori, H., & Shimizu, N. (2000) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.28.143 · Cited by 2
Localization microscopy for the study of amyloid fibril formation
Pinotsi, D., Schierle, G. S. K., Rees, E. J., & Kaminski, C. F. (2013) · Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE · doi:10.1117/12.2022589 · Cited by 2
Atypical parkinsonism, parkinsonism-plus syndromes, and secondary parkinsonian disorders
Fahn, S., Jankovic, J. J., & Hallett, M. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-2369-4.00009-3 · Cited by 2
Effects of Formaldehyde on Protein (Tau) Aggregation and Cytotoxicity
He, R. (2017) · Springer eBooks · doi:10.1007/978-94-024-1177-5_7 · Cited by 2
Neurodegeneration and the Ordered Assembly of Tau
Goedert, M. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811304-2.00004-3 · Cited by 3
Self-citationTau Pathology and Neurodegenerative Disorders
Takashima, A., Soeda, Y., Koike, R., & Maeda, S. (2022) · Springer eBooks · doi:10.1007/978-981-16-7977-3_22 · Cited by 2
Binding of Tau Protein to the Ends of ex vivo Paired Helical Filaments
Santa‐María, I., Cuadros, R., Moreno, F. J., Muñoz, V., Ávila, J., & Hernández, F. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-13208 · Cited by 2
Gene-environment interactions in considering physical activity for the prevention of dementia
Bates, K. A. (2015) · AIMS molecular science · doi:10.3934/molsci.2015.3.359 · Cited by 2
Formation of a new fluorescence of human neuronal tau protein
Luo, J., Li, W., & He, R. (1999) · Chinese Science Bulletin · doi:10.1007/bf02896281 · Cited by 2
Neurotransmitter Receptor—G-Protein-Mediated Signal Transduction in Alzheimer’s Disease
Cowburn, R. F. (2000) · doi:10.1007/978-1-59259-019-3_5 · Cited by 2
dGAE(297-391) tau fragment promotes formation of CTE-like full-length tau filamentsPreprint
Kitoka, K., Lends, A., Kučinskas, G., Bula, A. L., Krasauskas, L., Smirnovas, V., Žilková, M., Kováčech, B., Škrabana, R., Hritz, J., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.02.01.526268 · Cited by 2
Mammeri, N. E., Dregni, A. J., Duan, P., & Hong, M. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.09.04.556256 · Cited by 2
Phosphatidylinositol (PI) Lipids Modulate the Binding of Tau Fibrils on Lipid BilayersPreprint
Chowdhury, U. D., Paul, A., & Bhargava, B. L. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.09.20.558589 · Cited by 2
Tau-Centric Therapies for Treating Alzheimer’s Disease
Quraishe, S., Cowan, C. M., & Mudher, A. K. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-803690-7.00005-3 · Cited by 1
Expanded Conformations of Monomeric Tau Initiate Its Amyloidogenesis**
Fernández‐Ramírez, M. D. C., Ng, K. K., Menéndez, M., Laurents, D. V., Hervás, R., & Carrión‐Vázquez, M. (2022) · Angewandte Chemie · doi:10.1002/ange.202209252 · Cited by 1
Biophysical Studies of Amyloid-Binding Fluorophores to Tau AD Core Fibrils Formed without Cofactors
Freitas, D. P., Saavedra, J., Cardoso, I., & Gomes, C. M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25189946 · Cited by 1
Effect of PHF-1 hyperphosphorylation on the seeding activity of C-terminal Tau fragments
Hajjar, L. E., Boll, E., Cantrelle, F., Bridot, C., Landrieu, I., & Smet‐Nocca, C. (2025) · Scientific Reports · doi:10.1038/s41598-025-91867-3 · Cited by 1
Gop, R. S., Adhikary, R., Venkatramani, A., Sengar, N., Singh, I. P., & Panda, D. (2025) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.4c00567 · Cited by 1
Impact of Lysine Acetylation Mutations on the Structure of Full-Length Tau Fibrils
Dregni, A. J., & Hong, M. (2025) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5c00149 · Cited by 1
Multifunctional molecular agent for tau-targeted combinational therapy of Alzheimer’s disease
Wu, J., Chai, K., Tu, Y., Fang, K., Shi, S., Hu, X., Liu, J., & Yao, T. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.110583 · Cited by 1
Tau Folding and Assembly Triggered by Electroreduction of Its Protonated Amino Acids
Masquelier, E., Fojut, S., Faraji, X., Tochikura, S. K., Yi, J., Sepunaru, L., Gordon, M. J., & Morse, D. E. (2025) · ACS electrochemistry. · doi:10.1021/acselectrochem.5c00213 · Cited by 1
Yang, J., Deng, Y., Qin, S., Chen, Z., Lu, Y., Ji, S., Hang, T., & Song, M. (2025) · Journal of Materials Chemistry B · doi:10.1039/d5tb01783a · Cited by 1
Garrahy, J. P. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251404970 · Cited by 1
Polyserine domains are toxic and exacerbate tau pathology in mice
Alstyne, M. V., Nguyen, V. L., Hoeffer, C. A., & Parker, R. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2527425122 · Cited by 5
A novel TGFβ1–Hs3st2–tau axis regulates tau pathology and synaptic integrity
Castillo‐Negrete, R., Merrick, H., Selvaraj, S., Huynh, M. B., Laffray, X., Thuraisamy, A., Diener, M., Jedlička, P., Ouidja, M. O., & Papy-García, D. (2026) · Frontiers in Neuroscience · doi:10.3389/fnins.2025.1726022 · Cited by 1
Gabani, Z. Y., Singh, J., Hamlett, E. D., Granholm, A., & Margittai, M. (2026) · JACS Au · doi:10.1021/jacsau.5c01693 · Cited by 2
Pathogenesis of neurodegenerative diseases via templated recruitment
Guo, J. (2013) · ScholarlyCommons (University of Pennsylvania) · Cited by 1
The Conformations of Tau Protein and its Aggregation into Alzheimer Paired Helical Filaments
Mandelkow�, E., Friedhoff, P., Biernat, J., & Mandelkow, E. (1998) · Advances in behavioral biology · doi:10.1007/978-1-4615-5337-3_32 · Cited by 1
The Aetiology of Alzheimer’s Disease: Diverse Routes into a Common Tau Pathway
Harrington, C. R. (2001) · Elsevier eBooks · doi:10.1016/b978-044450811-9/50030-6 · Cited by 1
Furukawa, Y. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-394431-3.00019-5 · Cited by 1
Sergeant, N., & Buée, L. (2010) · Advances in neurobiology · doi:10.1007/978-1-4419-6787-9_4 · Cited by 1
Direct Observation of Aggregation‐Induced Backbone Conformational Changes in Tau Peptides
Jiji, A. C., Shine, A., & Vijayan, V. (2016) · Angewandte Chemie · doi:10.1002/ange.201606544 · Cited by 1
Metadata
- Authors
- Goedert, M., Jakes, R., Spillantini, M. G., Hasegawa, M., Smith, M. J., & Crowther, R. A.
- Affiliations
- MRC Laboratory of Molecular Biology (GB)
- Venue
- Nature
- Published
- 1996-10
- Volume
- 383
- Issue
- 6600
- Pages
- 550-553
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1994282166
- Cited by
- 1,036
- References
- 32
- Citations by year
- 2026: 29 · 2025: 35 · 2024: 43 · 2023: 47 · 2022: 57 · 2021: 50 · 2020: 43 · 2019: 47 · 2018: 50 · 2017: 48 · 2016: 26 · 2015: 27 · 2014: 20 · 2013: 42 · 2012: 30
- FWCI
- 27.47
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- tau protein, paired helical filaments, Alzheimer's disease, neurofibrillary tangles, sulfated glycosaminoglycans, heparin, heparan sulfate, tau hyperphosphorylation, microtubule binding, microtubule disassembly, tau isoforms, neurofibrillary pathology
- MeSH terms
- Alzheimer Disease, Escherichia coli, Heparin, Heparitin Sulfate, Heparan Sulfate, Hippocampus, Humans, Neurofibrils, Phosphorylation, Protein Binding, Recombinant Proteins, tau Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review